Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study

NCT03068208 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT03068208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03068208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study
Lead sponsor
Chulalongkorn University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
June 30, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lichen amyloidosis